Israel - English - Ministry of Health

unipharm ltd, israel - paroxetine as hydrochloride - tablets - paroxetine as hydrochloride 30 mg - paroxetine - paroxetine - treatment of symptoms of depressive illness of all types including depression accompanied by anxiety. treatment of symptoms and prevention of relapse of obsessive compulsive disorder (ocd). treatment of symptoms and prevention of relapse of panic disorder with or without agoraphobia.treatment of symptoms of social phobia.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - medroxyprogesterone acetate - suspension for injection - medroxyprogesterone acetate 104 mg / 0.65 ml - medroxyprogesterone - medroxyprogesterone - * sayana is indicated for long-term female contraception. each subcutaneous injection prevents ovulation and provides contraception for at least 13 weeks (+/- 1 week). however, it should be taken into consideration that the return to fertility (ovulation) may be delayed for up to one year .since loss of bone mineral density may occur in females of all ages who use sayana long-term, a risk/benefit assessment, which also takes into consideration the decrease in bone mineral density that occurs during pregnancy and/or lactation, should be considered.* use in adolescents (12-18 years)in adolescents, use of sayana is only indicated when other contraceptive methods are considered unsuitable or unacceptable, due to unknown long-term effects of bone loss associated with sayana during the critical period of bone accretion.sayana has not been studied in women under the age of 18 years but data is available for intramuscular medroxyprogesterone acetate in this population.

Israel - English - Ministry of Health

merck serono ltd - follitropin alfa; lutropin alfa - powder and solvent for solution for injection - follitropin alfa 150 iu; lutropin alfa 75 iu - follitropin alfa - follitropin alfa - pergoveris is indicated for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials, these patients were defined by an endogenous serum lh level < 1.2 iu/l.

Israel - English - Ministry of Health

sanofi israel ltd - zolpidem tartrate - film coated tablets - zolpidem tartrate 10 mg - zolpidem - zolpidem - indications are limited to treatment of severe sleep disorders in the following cases: - occasional insomnia - transient insomnia.

Israel - English - Ministry of Health

sanofi israel ltd - zolpidem tartrate - tablets extended release - zolpidem tartrate 6.25 mg - zolpidem - zolpidem - for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance (as measured by wake time after sleep onset).

Israel - English - Ministry of Health

sanofi israel ltd - zolpidem tartrate - tablets extended release - zolpidem tartrate 12.5 mg - zolpidem - zolpidem - for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance (as measured by wake time after sleep onset).

Israel - English - Ministry of Health

unipharm ltd, israel - amlodipine as besilate; valsartan - coated tablets - valsartan 160 mg; amlodipine as besilate 10 mg - valsartan - treatment of essential hypertension. duplex is indicated for patients whose blood pressure is not adequately controlled on monotherapy.

Israel - English - Ministry of Health

unipharm ltd, israel - amlodipine as besilate; valsartan - coated tablets - valsartan 160 mg; amlodipine as besilate 10 mg - valsartan - treatment of essential hypertension. duplex is indicated for patients whose blood pressure is not adequately controlled on monotherapy.

Israel - English - Ministry of Health

unipharm ltd, israel - amlodipine as besilate; valsartan - coated tablets - valsartan 160 mg; amlodipine as besilate 5 mg - valsartan - treatment of essential hypertension. duplex is indicated for patients whose blood pressure is not adequately controlled on monotherapy.

Israel - English - Ministry of Health

unipharm ltd, israel - amlodipine as besilate; valsartan - coated tablets - valsartan 160 mg; amlodipine as besilate 5 mg - valsartan - treatment of essential hypertension. duplex is indicated for patients whose blood pressure is not adequately controlled on monotherapy.